STRO | Sutro Biopharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	153.73M	67.77M	61.88M	42.72M	42.74M	38.42M	51.74M	59.73M
Cost of Revenue	6.82M	8.29M	9.77M	76.96M	65.61M	N/A	N/A	N/A
Gross Profit	146.91M	59.48M	52.11M	-34.24M	-22.88M	38.42M	N/A	N/A
Operating Expenses	236.19M	196.72M	160.40M	113.78M	98.20M	75.64M	71.01M	N/A
Selling, General & Admin	55.77M	59.54M	56.00M	36.82M	32.59M	21.38M	16.37M	14.82M
Research & Development	180.43M	137.17M	104.40M	76.96M	65.61M	54.26M	54.64M	43.55M
Other Operating Expenses	-180.43M	N/A	N/A	N/A	-4.35M	1.91M	N/A	N/A
Operating Income	-89.28M	-128.94M	-98.52M	-71.06M	-55.47M	-37.22M	-19.27M	1.36M
Other Expenses / Income	677.00K	12.24M	-7.01M	38.93M	-276.00K	1.91M	-416.00K	338.00K
Before Tax Income	-88.60M	-116.70M	-105.54M	-32.13M	-55.74M	-35.32M	-19.69M	1.70M
Income Tax Expenses	18.19M	2.50M	3.14M	4.08M	8.68M	3.53M	N/A	N/A
Net Income	-106.79M	-119.20M	-108.67M	-36.20M	-55.74M	-35.32M	-19.69M	1.70M
Interest Expenses	23.75M	3.35M	3.14M	4.08M	4.35M	1.62M	612.00K	N/A
Basic Shares Outstanding	60.16M	50.74M	46.12M	32.57M	22.96M	5.76M	5.51M	7.00M
Diluted Shares Outstanding	60.16M	50.74M	46.12M	32.57M	22.96M	5.76M	5.51M	7.00M
EBITDA	-82.46M	-125.49M	-93.10M	-65.25M	-46.62M	-29.16M	-14.09M	7.36M
EBITDA Margin	-53.64%	-185.16%	-150.46%	-152.74%	-109.08%	-75.89%	-27.22%	12.33%
EBIT	-64.85M	-113.36M	-102.40M	-28.05M	-42.71M	-30.16M	-19.08M	1.70M
EBIT Margin	-42.18%	-167.26%	-165.48%	-65.66%	-99.95%	-78.52%	-36.87%	2.85%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31